The recommended frequency of echocardiography in follow-up evaluation of patients with Kawasaki disease

Acta Paediatrica Taiwanica

Volumn 46, Issue 6, 2005, Pages

  Lee, Meng Hsun ^a   Dai, Zen Kong ^a   Lee, Min Sheng ^a   Hsu, Jong Hau ^a   Chuang, Hung Yi ^a   Wu, Jiunn Ren ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Coronary aneurysm; Echocardiography; Kawasaki disease

Indexed keywords

ARTICLE; COHORT ANALYSIS; CORONARY ARTERY ANEURYSM; CORONARY ARTERY DILATATION; ECHOCARDIOGRAPHY; FEMALE; FEVER; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; CORONARY ANEURYSM; ECHOCARDIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; INFANT; MUCOCUTANEOUS LYMPH NODE SYNDROME; RETROSPECTIVE STUDIES;

EID: 33645967177     PISSN: 16088115     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Kawasaki T, Kosaki F, Okawa S, Shigematsu I, Yanagawa H. A new infantile acute febrile mucocutaneous lymph node syndrome prevailing in Japan. Pediatrics 1974; 54:271-6.
2. Shulman ST, Inocencio J, Hirsch R. Kawasaki disease. Ped Clin N America 1995; 42:1205-22.
3. Yanagawa H, Nakamura Y, Yashiro M, et al. Incidence survey of Kawasaki disease in 1997 and 1998 in Japan. Pediatrics 2001; 107:E33.
4. Newburger JW, Takahashi M, Beiser AS, et al. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki disease. N Eng J Med 1991; 324:1633-9.
5. Hiraishi S, Misawa H, Takeda N, Horiguchi Y, Fujino N, Hirota H. Transthoracic ultrasound visualization of coronary aneurysm, stenosis, and occlusion in Kawasaki disease. Heart 2000; 83:400-5.
6. Dajani AS, Taubert KA, Gerber MA, et al. Guidelines for long-term management of patients with Kawasaki disease. Circulation 1994; 89:916-22.
7. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Pediatrics 2004; 114:1708-33.
8. Wu JR, Huang KP, Tu JG, et al. Study on coronary artery lesions in patients with Kawasaki disease: recent 9 years' experience. Kaohsiung J Med Sci 1993; 9:27-38.
9. Hwang KP, Wu JR, Huang LY, Liou CC, Huang TY. Clinical manifestation and effects of IVGG in patients with Kawasaki disease. Kaohsiung J Med Sci 1996; 12:159-66
10. Research Committee on Kawasaki Disease. Report of the Subcommittee on Standardization of Diagnostic Criteria and Reporting of Coronary Artery Lesions in Kawasaki Disease. Tokyo, Japan: Ministry of Health and Welfare; 1984.
11. Lue HC, Philips, Chen MR, et al. Surveillance of Kawasaki disease and review of the literature. Acta Paediatr Tw 2004; 45:8-14.
12. Chang LY, Chang IS, Lu CY, et al. Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. Pediatrics 2004; 114:678-82.
13. Scott JS, Ettedgui JA, Neches WH. Cost-effective use of echocardiography in children with Kawasaki disease. Pediatrics 1999; 104:E57-9.
14. McMorrow Tuohy AM, Tani LY, Cetta F, et al. How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease? Am J Cardiol 2001; 88:328-30.
15. Onouchi Z, Hamaoka K, et al. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens. Circ J 2005; 69:265-72.
16. Shinozaki M, Okubo I, Ishikawa N, Matsumoto Y, Imano N, Togashi K, et al. Factor VIII in blood of Kawasaki disease patients. J Jpn Pediatr Soc 1979; 83:170-8 (in Japanese).
17. Shirahata A, Nakamura T, Ariyoshi N. Blood coagulation status in patients beyond 1 year after the onset of Kawasaki disease. J Jpn Pediatr Soc 1990; 94:2608-13 (in Japanese).
18. Glode MD, Toffels S, Wiggins J Jr, Clarke SM, Hathaway WC. Effect of intravenous immune globulin on the coagulopathy in Kawasaki disease. J Pediatr 1989; 115:469-73.
19. Moriuchi H. Tissue plasminogen activator (t-PA) in Kawasaki disease and the effect of immunoglobulin therapy on the viewpoint of alteration of t-PA: especial reference with study on convalescent stage. J Jpn Pediatr Soc 1990; 94:1541-6 (in Japanese).
20. Sakai M, Asayama K, Otabe T, Kohri T, Shirahata A. Low tissue plasminogen activator relation to plasminogen activator inhibitor-1 as a marker of cardiac complication in children with Kawasaki disease. Clin Appl Thromb Hemost 2001; 7:214-8.
21. de Zorzi A, Colan SD, Gauvreau K, Baker AL, Sundel RP, Newburger JW. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 1998; 133:254-8.
22. Greil GF, Stuber M, Botnar RM, et al. Coronary magnetic resonance angiography in adolescents and young adults with Kawasaki disease. Circulation 2002; 105:908-11.
23. Frey EE, Matherne GP, Mahoney LT, Sato Y, Stanford W, Smith WL. Coronary artery aneurysms due to Kawasaki disease: diagnosis with ultrafast CT. Radiology 1988; 167:725-6.
24. Sato Y, Kato M, Inoue F, et al. Detection of coronary artery aneurysms, stenoses and occlusions by multislice spiral computed tomography in adolescents with Kawasaki disease. Circ J 2003; 67:427-30.
25. Sugimura T, Kato H, Inoue O, et al. Intravascular ultrasound of coronary arteries in children: assessment of the wall morphology and the lumen after Kawasaki disease. Circulation 1994; 89:258-65.